"Fructosamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An amino sugar formed when glucose non-enzymatically reacts with the N-terminal amino group of proteins. The fructose moiety is derived from glucose by the "classical" Amadori rearrangement.
| Descriptor ID |
D019270
|
| MeSH Number(s) |
D09.067.342.300
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fructosamine".
Below are MeSH descriptors whose meaning is more specific than "Fructosamine".
This graph shows the total number of publications written about "Fructosamine" by people in this website by year, and whether "Fructosamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fructosamine" by people in Profiles.
-
Shohat N, Goswami K, Breckenridge L, Held MB, Malkani AL, Shah RP, Schwarzkopf R, Parvizi J. Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi-institutional investigation. Sci Rep. 2021 01 26; 11(1):2227.
-
Shohat N, Tarabichi M, Tan TL, Goswami K, Kheir M, Malkani AL, Shah RP, Schwarzkopf R, Parvizi J. 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: a prospective multicentre study. Bone Joint J. 2019 07; 101-B(7_Supple_C):3-9.
-
Shohat N, Tarabichi M, Tischler EH, Jabbour S, Parvizi J. Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control. J Bone Joint Surg Am. 2017 Nov 15; 99(22):1900-1907.
-
Juraschek SP, Steffes MW, Miller ER, Selvin E. Alternative markers of hyperglycemia and risk of diabetes. Diabetes Care. 2012 Nov; 35(11):2265-70.
-
Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology (Carlton). 2012 Feb; 17(2):182-8.
-
Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care. 2003 Jan; 26(1):1-8.